BDX (BDX) holder files notice to sell 629 shares under SEC Rule 144
Rhea-AI Filing Summary
A shareholder of BDX has filed a notice under Rule 144 to sell 629 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 12/17/2025. The planned sale has an aggregate market value of $123,529.31, compared with 285,418,551 shares of the same class reported as outstanding.
The shares to be sold were acquired on 11/26/2025 as Restricted Stock Units from the issuer, in an amount of 629 units, with the same date listed as the date of payment and the nature of payment noted as "N/A." By signing the notice, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for BDX disclose?
The notice states that a BDX shareholder intends to sell 629 shares of common stock under Rule 144 on the NYSE, with an aggregate market value of $123,529.31.
What representation does the seller make about undisclosed information in the BDX Form 144?
By signing, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Is the BDX Form 144 sale connected to a Rule 10b5-1 trading plan?
The form includes a field for the Date of Plan Adoption or Giving of Instruction if relying on Rule 10b5-1, but no specific date is shown in the provided content.